Andrew Brenton
Turtle Creek Asset Management
Andrew Brenton Medpace Holdings Inc stake
total: 80
Turtle Creek Asset Management MEDP trades
- Total transactions:
- 5
- New positions:
- 1
- Added:
- 2
- Reduced:
- 2
- Held since:
- 2025 Q2
- Held for:
- 5 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Andrew Brenton holds 136,660 Medpace Holdings Inc (MEDP) shares with a market value of roughly $72.37M accounting for 2.83% of the overall portfolio. To date, the estimated cost basis is nearly $467.93 for "buy" trades and estimated average "sell" price is $525.74. Turtle Creek Asset Management first purchased MEDP in 2025 Q2, initially acquiring 11,000 shares. Since the initial investment in Medpace Holdings Inc (MEDP), Turtle Creek Asset Management has made 4 more transactions.
When did Andrew Brenton buy Medpace Holdings Inc (MEDP)?
Andrew Brenton first invested in Medpace Holdings Inc (MEDP) in 2025 Q2 at the reported quarter-end price of $313.86 per share.
What's the cost basis of Turtle Creek Asset Management's MEDP stake?
The estimated cost basis for Medpace Holdings Inc (MEDP) stake is around $467.93 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $467.93
- Weighted AVG sell price:
- $525.74
Andrew Brenton's historical trades in Medpace Holdings Inc
5 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
2.83%
|
136,660
|
$529.59
|
$72,373,769
|
+0.80% (+1,090)
|
+0.02%
|
|
2026 Q1
|
2.44%
|
135,570
|
$480.19
|
$65,099,358
|
+4,741.79% (+132,770)
|
+2.39%
|
|
2025 Q4
|
0.07%
|
2,800
|
$561.65
|
$1,572,620
|
-41.67% (-2,000)
|
-0.03%
|
|
2025 Q3
|
0.07%
|
4,800
|
$514.16
|
$2,467,968
|
-56.36% (-6,200)
|
-0.09%
|
|
2025 Q2
|
0.10%
|
11,000
|
$313.86
|
$3,452,460
|
new
|
+0.1%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.